论文部分内容阅读
目的:探讨麻仁丸联合甲硝唑和头孢曲松对热毒炽盛型盆腔炎的治疗效果,为临床应用提供参考。方法:从2011年6月—2012年6月本院收治的盆腔炎患者中筛选出108例热毒炽盛型患者,随机分为实验组和对照组两组,各54例,对照组予以头孢曲松和甲硝唑治疗,实验组在对照组基础上加服麻仁丸。对比分析两组疗效和症状改善指标。结果:实验组总有效率96.29%、对照组总有效率为94.44%,差异无统计学意义(P>0.05);实验组腹痛缓解时间、白细胞数恢复正常时间、妇检恢复正常时间较对照组缩短,差异有统计学意义(P<0.05)。结论:麻仁丸联合西药甲硝唑和头孢曲松可显著提高热毒炽盛型盆腔炎患者的康复速度和治疗效率,值得临床推广应用。
Objective: To investigate the effect of Maren pill combined with metronidazole and ceftriaxone on the treatment of hyperthermic flare-type pelvic inflammatory disease, and provide a reference for clinical application. Methods: From June 2011 to June 2012, 108 cases of patients with pelvic inflammatory disease were selected and randomly divided into two groups (experimental group and control group, 54 cases each). The control group was treated with cefotaxime Song and metronidazole treatment, the experimental group in the control group plus Maren pill. Comparative analysis of two groups of indicators of efficacy and symptoms. Results: The total effective rate was 96.29% in the experimental group and 94.44% in the control group, the difference was not statistically significant (P> 0.05); the pain relief time and the number of white blood cells returned to normal in the experimental group, Shortened, the difference was statistically significant (P <0.05). Conclusion: Maren pill combined with Western medicine metronidazole and ceftriaxone can significantly improve the rate of heat recovery and treatment of patients with hot flaming pelvic inflammatory disease, which is worthy of clinical application.